FluWatch report: November 27 to December 3, 2022 (week 48)

Download in PDF format
(2.37 MB, 12 pages)

Organization: Public Health Agency of Canada

Published: 2022-12-09

Weekly Highlights

  • At the national level, influenza activity continues to remain above expected levels typical of this time of year as we enter the sixth week of the national influenza epidemic. At the national level, all surveillance indicators are steady or increasing and nearly all are above expected levels typical of this time of year.

Virologic

  • In week 48, a total of 9,855 laboratory detections (9,842 influenza A and 13 influenza B) were reported.
  • Among subtyped influenza A detections in week 48, 97% (2,132) were influenza A(H3N2) and 3% (67) were influenza A(H1N1).
  • Among detections for which age information was reported in week 48 (6,009), 41% (2,454) of detections were in individuals aged 0-19 years old, down slightly from 45% (2,575) in week 47.

Syndromic

  • The percentage of visits for influenza-like illness (ILI) was 3.7% in week 48. The percentage visits for ILI is above levels typical of this time of year.
  • The percentage of FluWatchers reporting fever and cough was 3.1% in week 48. The percentage of FluWatchers reporting cough and fever is above the seasonal average.

Outbreaks

  • From August 28, 2022 to December 3, 2022 (weeks 35 to 48), 292 laboratory-confirmed influenza outbreaks have been reported.

Severe Outcomes

  • The IMPACT network continues to report elevated weekly numbers of influenza-associated hospitalizations among the pediatric population. Currently, the weekly number of pediatric hospitalizations being reported is above levels typically seen at the peak of the influenza season. In week 48, 247 influenza-associated hospitalizations were reported.
  • The highest cumulative hospitalization rates are among children under 5 years of age (56/100,000 population) and adults 65 years of age and older 49/100,000 population).

On this page

Influenza/Influenza-like Illness Activity - Geographic Spread

In week 48, almost all regions in Canada reported influenza activity with five regions in three provinces (P.E.I., Man. and Alta.) reporting widespread activity (Figure 1).

Figure 1 - Map of influenza/ILI activity by province and territory, Canada, week 2022-48

Number of Regions Reporting in Week 48: 53 out of 53

Figure 1. Text version below
Figure 1 - Text description
Province Influenza Surveillance Region Activity Level
N.L. Eastern Localized
N.L. Labrador-Grenfell Sporadic
N.L. Central Localized
N.L. Western Sporadic
P.E.I. Prince Edward Island Widespread
N.S. Zone 1 - Western Localized
N.S. Zone 2 - Northern Localized
N.S. Zone 3 - Eastern Sporadic
N.S. Zone 4 - Central Sporadic
N.B. Region 1 Localized
N.B. Region 2 Localized
N.B. Region 3 Localized
N.B. Region 4 Localized
N.B. Region 5 Localized
N.B. Region 6 Localized
N.B. Region 7 Localized
Que. Nord-est Sporadic
Que. Québec et Chaudieres-Appalaches Sporadic
Que. Centre-du-Québec Sporadic
Que. Montréal et Laval Sporadic
Que. Ouest-du-Québec Sporadic
Que. Montérégie Sporadic
Ont. Central East Localized
Ont. Central West Localized
Ont. Eastern Localized
Ont. North East Localized
Ont. North West Sporadic
Ont. South West Localized
Ont. Toronto Localized
Man. Northern Regional Sporadic
Man. Prairie Mountain Sporadic
Man. Interlake-Eastern Sporadic
Man. Winnipeg Widespread
Man. Southern Health Sporadic
Sask. North Localized
Sask. Central Localized
Sask. South Localized
Alta. North Zone Widespread
Alta. Edmonton Localized
Alta. Central Zone Widespread
Alta. Calgary Localized
Alta. South Zone Widespread
B.C. Interior Localized
B.C. Fraser Sporadic
B.C. Vancouver Coastal Localized
B.C. Vancouver Island Sporadic
B.C. Northern Sporadic
Y.T. Yukon Localized
N.W.T. North Sporadic
N.W.T. South Sporadic
Nvt. Qikiqtaaluk Sporadic
Nvt. Kivalliq Sporadic
Nvt. Kitimeot No Activity

Laboratory-Confirmed Influenza Detections

In week 48, a total of 9,855 laboratory detections (9,842 influenza A and 13 influenza B) were reported.

The following results were reported from sentinel laboratories across Canada in week 48 (Figures 2 and 3):

To date this season (August 28, 2022 to December 3, 2022):

For more detailed weekly and cumulative influenza data, see the text descriptions for Figures 2 and 3 or the Respiratory Virus Detections in Canada Report.

Figure 2 - Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, week 2022-35 to 2022-48

Number of Laboratories Reporting in Week 48: 33 out of 35

Figure 2. Text version below
Figure 2 - Text description
Surveillance Week A(Unsubtyped) A(H3N2) A(H1N1) Influenza B Percent Positive A Percent Positive B
35 12 10 2 3 0.2 0.0
36 9 5 1 5 0.1 0.0
37 19 9 3 2 0.2 0.0
38 26 35 20 3 0.5 0.0
39 44 53 22 5 0.7 0.0
40 63 66 16 4 1.0 0.0
41 120 110 20 1 1.4 0.0
42 217 204 11 9 2.4 0.1
43 417 595 23 6 5.6 0.0
44 1034 1351 54 7 10.9 0.0
45 1897 2268 69 11 16.0 0.0
46 3210 2963 97 16 19.8 0.1
47 5531 2851 151 16 23.9 0.0
48 6893 2132 67 13 23.8 0.0
Figure 3 - Percentage of tests positive in Canada compared to previous seasons, week 2022-35 to 2022-48
Figure 3. Text version below.

The shaded area represents the maximum and minimum number of influenza tests or percentage of tests positive reported by week from seasons 2014-2015 to 2019-2020. Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

The epidemic threshold is 5% tests positive for influenza. When it is exceeded, and a minimum of 15 weekly influenza detections are reported, a seasonal influenza epidemic is declared.

Figure 3 - Text description
Surveillance Week Percentage of tests positive, 2022-2023 Percentage of tests positive, 2021-2022 Percentage of tests positive, 2020-2021 Maximum Percentage of Tests Positive Minimum Percentage of Tests Positive Average Percentage of Tests Positive
35 0.2 0.0 0.0 1.9 0.1 0.8
36 0.2 0.0 0.0 2.3 0.3 1.1
37 0.3 0.0 0.0 1.8 0.4 1.0
38 0.5 0.0 0.0 2.4 0.5 1.3
39 0.7 0.0 0.0 2.9 0.7 1.7
40 1.0 0.0 0.0 2.3 1.1 1.7
41 1.5 0.1 0.0 3.0 1.3 1.7
42 2.5 0.1 0.0 3.4 0.9 2.2
43 5.6 0.1 0.0 5.3 0.8 2.8
44 10.9 0.2 0.1 8.5 1.2 3.7
45 16.0 0.1 0.0 10.1 1.4 4.6
46 19.9 0.2 0.0 14.1 1.5 6.1
47 23.9 0.2 0.1 15.4 1.4 7.7
48 23.8 0.3 0.1 18.2 0.8 10.6
49 - 0.3 0.0 19.7 1.6 13.0
50 - 0.3 0.0 27.0 2.4 16.8
51 - 0.2 0.0 29.1 3.3 20.1
52 - 0.1 0.0 34.5 4.3 24.5
1 - 0.1 0.0 31.7 5.8 23.4
2 - 0.1 0.0 29.1 7.1 23.0
3 - 0.1 0.0 30.1 12.2 23.6
4 - 0.1 0.0 29.5 15.9 24.0
5 - 0.0 0.0 30.6 19.6 24.9
6 - 0.1 0.0 32.4 17.9 25.0
7 - 0.0 0.0 32.5 16.3 25.1
8 - 0.1 0.0 32.9 17.5 25.1
9 - 0.1 0.0 34.3 16.8 24.6
10 - 0.2 0.0 36.0 16.0 23.2
11 - 0.3 0.0 31.4 16.2 21.4
12 - 0.9 0.0 30.0 15.0 20.1
13 - 1.5 0.0 28.3 14.5 19.6
14 - 2.5 0.0 23.2 12.7 17.9
15 - 3.9 0.0 20.7 11.9 16.3
16 - 7.0 0.0 18.5 11.6 14.5
17 - 9.7 0.0 17.3 9.8 12.8
18 - 11.3 0.0 13.0 7.9 10.3
19 - 12.6 0.0 11.9 5.0 9.0
20 - 10.4 0.0 9.1 3.2 7.2
21 - 9.8 0.0 7.4 3.0 5.6
22 - 8.4 0.0 5.0 2.2 3.9
23 - 7.0 0.0 4.4 0.9 2.9
24 - 5.0 0.0 4.4 0.8 2.2
25 - 3.0 0.0 3.9 0.6 1.9
26 - 2.3 0.0 3.1 0.7 1.8
27 - 1.2 0.0 2.8 0.4 1.5
28 - 0.8 0.0 1.8 0.4 0.9
29 - 0.7 0.0 1.6 0.5 1.1
30 - 0.4 0.0 1.5 0.5 0.9
31 - 0.3 0.0 1.9 0.6 1.1
32 - 0.2 0.0 1.2 0.5 0.9
33 - 0.2 0.0 1.7 0.4 0.9
34 - 0.2 0.0 1.6 0.4 0.9

Figure 4 - Proportion of positive influenza specimens by type or subtype and age-group reported through case-based laboratory reporting, Canada, week 2022-35 to 2022-48

Figure 4. Text version below.

Laboratory data notes:

Testing for influenza and other respiratory viruses has been influenced by the current COVID-19 pandemic. Changes in laboratory testing practices may affect the comparability of data to previous seasons.

Due to different testing protocols of laboratories across Canada, some influenza A subtype detection counts may not be included in total influenza A detection counts and percent positivity calculations.

Figure 4 - Text description
a) Proportion of influenza A and B by age-group
Age Group Proportion of Influenza A Proportion of Influenza B Total Number Influenza Detections
0 to 4 99.7% 0.3% 3805
5 to 19 99.8% 0.2% 6188
20 to 44 99.6% 0.4% 4046
45 to 64 99.8% 0.2% 2358
65+ 99.7% 0.3% 4589
b) Proportion of subtyped influenza A(H1N1) and A(H3N2) by age-group
Age Group Proportion of A(H1N1) Proportion of A(H3N2) Total Number of Subtyped Influenza Detections
0 to 4 2.9% 97.1% 2012
5 to 19 2.8% 97.2% 2919
20 to 44 4.8% 95.2% 1927
45 to 64 7.7% 92.3% 1087
65+ 4.8% 95.2% 2132

Syndromic / Influenza-like Illness Surveillance

Healthcare Practitioners Sentinel Surveillance

In week 48, 3.7% of visits to healthcare professionals were due to influenza-like illness (ILI) (Figure 5). The percentage of visits for ILI is above expected levels for this time of year.

ILI symptoms are not specific to any one respiratory pathogen and can be due to influenza, or other respiratory viruses, including respiratory syncytial virus and SARS-CoV-2, the virus that causes COVID-19. This makes the percentage of visits for ILI an important indicator of overall respiratory illness morbidity in the community in the presence of co-circulating viruses.

This indicator should be interpreted with caution as there have been changes in healthcare seeking behavior of individuals and a smaller number of sentinels reporting compared to previous seasons.

Figure 5 - Percentage of visits for ILI reported by sentinels by report week, Canada, weeks 2022-35 to 2022-48

Number of Sentinels Reporting in Week 48: 38

Figure 5. Text version below.

The shaded area represents the maximum and minimum percentage of percentage of participants reporting cough and fever by week, from seasons 2014-2015 to 2019-2020. Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 5 - Text description
Surveillance Week 2022-2023 2021-2022 2020-2021 Average Min Max
35 0.6% 0.6% 0.1% 0.6% 0.4% 0.9%
36 0.9% 1.2% 0.2% 0.6% 0.4% 0.9%
37 0.7% 0.6% 0.4% 0.7% 0.5% 1.0%
38 0.8% 0.9% 0.3% 0.7% 0.6% 1.0%
39 1.0% 1.0% 0.4% 0.9% 0.5% 1.2%
40 0.7% 0.5% 0.2% 1.2% 0.8% 1.7%
41 1.9% 1.1% 0.4% 1.7% 0.8% 2.8%
42 1.4% 1.2% 0.5% 1.6% 1.2% 2.1%
43 1.6% 0.9% 0.3% 1.2% 0.8% 1.7%
44 1.5% 0.6% 0.3% 1.2% 0.7% 1.7%
45 2.2% 1.0% 0.4% 1.2% 0.9% 1.5%
46 2.3% 0.9% 0.8% 1.4% 1.2% 1.8%
47 3.6% 0.7% 0.3% 1.6% 1.1% 2.2%
48 3.7% 1.1% 0.5% 1.5% 1.1% 2.2%
49 - 0.9% 0.5% 1.7% 1.0% 2.8%
50 - 1.1% 0.4% 1.5% 1.1% 1.7%
51 - 1.7% 0.5% 1.9% 1.4% 2.7%
52 - 1.5% 0.5% 2.0% 1.0% 3.1%
1 - 2.1% 0.7% 3.4% 1.9% 5.4%
2 - 1.6% 0.4% 3.4% 1.8% 5.7%
3 - 1.4% 0.2% 2.3% 1.3% 3.7%
4 - 0.9% 0.3% 2.0% 1.1% 2.9%
5 - 1.0% 0.2% 2.1% 1.4% 3.1%
6 - 0.7% 0.5% 2.4% 1.4% 4.0%
7 - 0.7% 0.3% 2.4% 0.9% 3.5%
8 - 0.8% 0.2% 2.3% 0.8% 3.4%
9 - 0.7% 0.2% 2.3% 0.9% 3.1%
10 - 0.9% 0.2% 2.0% 1.0% 2.8%
11 - 0.6% 0.2% 1.9% 1.1% 2.8%
12 - 0.8% 0.3% 1.6% 0.6% 2.6%
13 - 1.2% 0.4% 1.6% 1.1% 2.6%
14 - 1.1% 0.2% 1.7% 1.1% 3.0%
15 - 1.2% 0.3% 1.3% 0.9% 1.9%
16 - 1.5% 0.3% 1.2% 0.8% 1.7%
17 - 1.3% 0.4% 1.2% 0.7% 1.7%
18 - 1.8% 0.5% 1.3% 0.5% 2.0%
19 - 1.7% 0.3% 0.9% 0.6% 1.3%
20 - 1.5% 0.5% 1.1% 0.6% 1.5%
21 - 1.4% 0.3% 0.9% 0.5% 1.3%
22 - 1.0% 0.3% 0.7% 0.3% 1.0%
23 - 1.1% 0.2% 0.8% 0.6% 1.0%
24 - 1.3% 0.2% 0.7% 0.6% 1.0%
25 - 1.0% 0.2% 0.6% 0.4% 0.8%
26 - 0.8% 0.2% 0.8% 0.5% 1.4%
27 - 1.7% 0.3% 0.6% 0.5% 0.7%
28 - 1.0% 0.1% 0.7% 0.5% 1.3%
29 - 0.9% 0.3% 0.9% 0.6% 1.7%
30 - 1.3% 0.2% 0.6% 0.2% 0.9%
31 - 0.9% 0.2% 0.4% 0.2% 0.6%
32 - 0.9% 0.2% 0.8% 0.3% 1.2%
33 - 0.8% 0.3% 0.7% 0.4% 1.3%
34 - 1.0% 0.5% 0.7% 0.4% 1.5%

FluWatchers

In week 48, 10,909 participants reported to FluWatchers, of which 3.1% reported symptoms of cough and fever (Figure 6). The percentage of FluWatchers who have reported cough and fever is above the seasonal average.

The reports of cough and fever are not specific to any one respiratory pathogen and can be due to influenza, or other respiratory viruses, including respiratory syncytial virus, rhinovirus, and SARS-CoV-2, the virus that causes COVID-19. This makes the proportion of individuals reporting cough and fever an important indicator of overall respiratory illness activity in the community in the presence of co-circulating viruses.

FluWatchers reporting is not impacted by changes in health services or health seeking behaviours.

Among the 338 participants who reported cough and fever:

The Northwest Territories had the highest participation rate this week (51 participants per 100,000 population) and the neighbourhood with postal code, K0A had the highest number of participants (152). See what is happening in your neighbourhood! Downloadable datasets are also available on Open Maps.

If you are interested in becoming a FluWatcher, sign up today.

Figure 6 - Percentage of FluWatchers reporting cough and fever, Canada, week 2022-35 to 2022-48

Number of Participants Reporting in Week 48: 10,909

Figure 6. Text version below.

The shaded area represents the maximum and minimum percentage of percentage of participants reporting cough and fever by week, from seasons 2014-2015 to 2019-2020. Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 6 - Text description
Surveillance Week 2022-2023 2021-2022 2020-2021 Average Min Max
35 1.3% 0.2% 0.2% N/A N/A N/A
36 1.2% 0.3% 0.2% N/A N/A N/A
37 1.6% 0.5% 0.4% N/A N/A N/A
38 1.8% 0.5% 0.3% N/A N/A N/A
39 2.3% 0.5% 0.4% N/A N/A N/A
40 2.4% 0.6% 0.5% 2.5% 2.2% 2.7%
41 2.0% 0.5% 0.4% 2.2% 1.8% 2.6%
42 2.0% 0.4% 0.3% 1.8% 1.6% 2.0%
43 2.3% 0.5% 0.2% 1.9% 1.5% 2.2%
44 2.6% 0.5% 0.3% 1.6% 1.4% 1.8%
45 3.0% 0.5% 0.3% 1.8% 1.4% 2.3%
46 2.9% 0.4% 0.3% 1.8% 1.2% 2.2%
47 3.1% 0.6% 0.3% 1.9% 1.4% 2.4%
48 3.1% 0.5% 0.3% 2.4% 1.7% 3.4%
49 N/A 0.4% 0.2% 2.6% 2.0% 3.2%
50 N/A 0.6% 0.1% 2.9% 2.1% 3.8%
51 N/A 1.0% 0.2% 3.2% 2.5% 3.9%
52 N/A 1.5% 0.1% 4.0% 2.8% 5.4%
1 N/A 1.1% 0.1% 3.8% 2.9% 4.8%
2 N/A 1.0% 0.2% 2.9% 1.9% 3.9%
3 N/A 0.8% 0.1% 3.3% 2.3% 4.8%
4 N/A 0.6% 0.1% 3.1% 2.1% 4.2%
5 N/A 0.6% 0.2% 3.2% 2.6% 3.6%
6 N/A 0.5% 0.1% 3.5% 2.8% 4.3%
7 N/A 0.4% 0.2% 3.2% 2.6% 3.8%
8 N/A 0.5% 0.1% 3.1% 2.5% 3.6%
9 N/A 0.5% 0.1% 2.8% 2.4% 3.5%
10 N/A 0.6% 0.2% 2.6% 2.1% 3.1%
11 N/A 0.9% 0.2% 2.3% 1.9% 2.6%
12 N/A 1.2% 0.2% 2.6% 2.5% 2.8%
13 N/A 1.8% 0.2% 2.5% 2.0% 3.1%
14 N/A 2.3% 0.2% 2.1% 1.3% 2.6%
15 N/A 1.9% 0.2% 1.8% 1.6% 1.9%
16 N/A 1.9% 0.1% 2.0% 1.5% 2.4%
17 N/A 1.6% 0.2% 1.7% 1.4% 2.3%
18 N/A 1.4% 0.2% 1.5% 1.2% 2.1%
19 N/A 1.3% 0.1% N/A N/A N/A
20 N/A 1.2% 0.2% N/A N/A N/A
21 N/A 1.2% 0.1% N/A N/A N/A
22 N/A 1.2% 0.1% N/A N/A N/A
23 N/A 1.2% 0.1% N/A N/A N/A
24 N/A 1.3% 0.1% N/A N/A N/A
25 N/A 1.3% 0.1% N/A N/A N/A
26 N/A 1.8% 0.2% N/A N/A N/A
27 N/A 2.0% 0.1% N/A N/A N/A
28 N/A 1.9% 0.2% N/A N/A N/A
29 N/A 1.8% 0.2% N/A N/A N/A
30 N/A 1.6% 0.2% N/A N/A N/A
31 N/A 1.3% 0.2% N/A N/A N/A
32 N/A 1.2% 0.3% N/A N/A N/A
33 N/A 1.4% 0.3% N/A N/A N/A
34 N/A 1.3% 0.5% N/A N/A N/A

Influenza Outbreak Surveillance

In week 48, 66 laboratory-confirmed influenza outbreaks were reported in Canada (36 in long-term care facilities (LTC), 17 in facilities categorized as ‘other', and 13 in acute care facilities). All outbreaks were due to influenza A. 68 ILI outbreaks were reported in schools/daycares.

To date this season (August 28, 2022 to December 3, 2022):

Outbreaks of ILI are not specific to any one respiratory pathogen and can be due influenza, or other respiratory viruses, including respiratory syncytial virus, rhinovirus, COVID-19, or a mixture of viruses. Many respiratory viruses in addition to the flu commonly circulate during the fall and winter, and can cause clusters of cases with respiratory illness which could be captured as ILI.

Number of provinces and territoriesFootnote 1 reporting in week 48: 13 out of 13

Figure 7: Number of new outbreaks of laboratory-confirmed influenza by report week, Canada, weeks 2022-35 to 2022-48

Figure 7. Text version below.

Figure 7 - Text description
Surveillance Week Acute Care Facilities Long Term Care Facilities Other Schools and Daycares Remote and/or Isolated Communities
35 0 0 1 0 0
36 0 1 0 0 0
37 0 0 0 0 0
38 1 0 0 0 0
39 0 2 1 0 0
40 0 2 3 0 0
41 1 2 1 0 0
42 3 1 2 0 0
43 1 8 6 3 0
44 1 10 12 1 0
45 12 15 7 0 0
46 12 35 17 0 0
47 13 32 13 0 7
48 13 36 17 0 0

Influenza Severe Outcomes Surveillance

Provincial/Territorial Influenza Hospitalizations and Deaths

In week 48, 212 influenza-associated hospitalizations and 31 ICU admissions were reported by participating provinces and territoriesFootnote 2. This week, 6 influenza-associated deaths were reported.

To date this season 1,670 influenza-associated hospitalizations were reported (August 28, 2022 to December 3, 2022) by participating provinces and territories:

To date this season (August 28, 2022 to December 3, 2022), 160 ICU admissions and 54 influenza-associated deaths were reported.

Number of provinces and territories reporting in week 48: 9 out of 9

Figure 8 – Cumulative rates of influenza-associated hospitalizations by age-group and surveillance week, Canada, participating provinces and territories, week 2022-35 to 2022-48

Figure 8. Text version below.

Figure 8 - Text description
Surveillance Week 0-4 yrs 5-19 yrs 20-44 yrs 45-64 yrs 65+ yrs Overall
35 0.2 - 0.0 0.0 0.1 0.0
36 0.2 - 0.0 0.0 0.1 0.1
37 0.2 - 0.0 0.1 0.4 0.1
38 0.2 - 0.0 0.1 0.4 0.1
39 0.2 - 0.0 0.1 0.7 0.2
40 0.2 - 0.1 0.2 0.7 0.2
41 0.2 0.1 0.1 0.2 1.2 0.3
42 0.7 0.1 0.3 0.4 1.5 0.5
43 2.5 1.1 0.5 0.9 2.7 1.2
44 8.5 3.1 1.0 1.9 5.6 2.8
45 19.5 6.2 2.2 4.4 15.0 6.6
46 34.7 9.4 4.1 6.7 27.6 11.3
47 51.4 14.2 6.4 10.7 42.3 17.4
48 56.4 15.1 7.6 12.7 49.3 19.9

Pediatric Influenza Hospitalizations and Deaths

In week 48, 247 influenza-associated pediatric (≤16 years of age) hospitalizations and 34 ICU admissions were reported by the Immunization Monitoring Program Active (IMPACT) network. The number of weekly influenza-associated hospitalizations is well above levels typical of this time of year and is above levels typically seen at the peak of the influenza season (Figure 9). All hospitalisations reported in week 48 were associated with influenza A. This week, less than 5 influenza-associated pediatric deaths were reported.

To date this season (August 28, 2022 to December 3, 2022), 959 pediatric influenza-associated hospitalizations, 131 ICU admissions and 5 influenza-associated pediatric deaths have been reported. Children aged between 2-4 years and 5-9 years account for more than 55% of the reported pediatric hospitalizations (Figure 10).

Figure 9 – Number of pediatric (≤16 years of age) hospitalizations reported by the IMPACT network, by week, Canada, week 2022-35 to 2022-48

Figure 9. Text version below.

Figure 9 - Text description
Surveillance week 2022-2023 2021-2022 Average Min Max
35 1 0 0 0 1
36 1 0 1 0 2
37 0 0 1 0 2
38 1 0 1 0 2
39 1 0 1 0 3
40 1 0 1 0 2
41 4 0 2 0 3
42 7 0 3 0 7
43 41 0 4 1 11
44 79 0 6 1 21
45 152 0 9 2 36
46 196 0 12 1 37
47 228 1 11 1 35
48 247 1 20 2 46
49 #N/A 1 21 3 41
50 #N/A 0 31 4 54
51 #N/A 2 44 5 82
52 #N/A 1 63 14 103
1 #N/A 1 62 21 107
2 #N/A 0 50 12 100
3 #N/A 0 51 27 80
4 #N/A 0 58 34 90
5 #N/A 0 59 25 120
6 #N/A 0 60 15 115
7 #N/A 0 59 17 118
8 #N/A 1 65 25 134
9 #N/A 1 57 12 151
10 #N/A 0 54 17 135
11 #N/A 0 51 16 118
12 #N/A 0 39 13 87
13 #N/A 8 32 15 66
14 #N/A 7 28 12 56
15 #N/A 18 25 11 56
16 #N/A 19 23 11 41
17 #N/A 23 19 9 37
18 #N/A 48 16 8 28
19 #N/A 36 11 5 19
20 #N/A 29 10 0 18
21 #N/A 32 6 4 9
22 #N/A 14 6 1 9
23 #N/A 16 3 1 7
24 #N/A 12 3 1 6
25 #N/A 9 2 0 5
26 #N/A 6 1 0 3
27 #N/A 3 1 0 2
28 #N/A 7 1 0 2
29 #N/A 2 1 0 3
30 #N/A 3 1 0 1
31 #N/A 1 0 0 0
32 #N/A 0 0 0 0
33 #N/A 1 0 0 2
34 #N/A 0 1 0 2
Figure 10 – Cumulative numbers of pediatric hospitalizations (≤16 years of age) with influenza by age-group reported by the IMPACT network, Canada, week 2022-35 to 2022-48

Figure 10. Text version below.

Figure 10 - Text description
Age Group Total
0-5 mo 94
6-23 mo 154
2-4 yr 286
5-9 yr 251
10-16 yr 174

Influenza Strain Characterization

Since September 1, 2022, the National Microbiology Laboratory (NML) has characterized 79 influenza viruses (72 A(H3N2), 7 A(H1N1)) received from Canadian laboratories.

Genetic Characterization of Influenza A(H3N2)

One influenza A(H3N2) virus did not grow to sufficient hemagglutination titers for antigenic characterization by hemagglutination inhibition (HI) assays. Therefore, NML has performed genetic characterization to determine the genetic group identity of this virus.

Sequence analysis of the HA gene of the virus showed that it belonged to genetic group 3C.2a1b.2a2.

A/Darwin/6/2021 (H3N2)-like virus is an influenza A/H3N2 component of the 2022-23 Northern Hemisphere influenza vaccine and belongs to genetic group 3C.2a1b.2a2.

Antigenic Characterization

Influenza A(H3N2)

Influenza A(H1N1)

Antiviral Resistance

The NML also tests influenza viruses received from Canadian laboratories for antiviral resistance.

Oseltamivir

70 influenza viruses (63 A(H3N2) and 7 A(H1N1)) were tested for resistance to oseltamivir and it was found that:

Zanamivir

70 influenza viruses (63 A(H3N2) and 7 A(H1N1)) were tested for resistance to zanamivir and it was found that:

Influenza Vaccine Monitoring

Vaccine monitoring refers to activities related to the monitoring of influenza vaccine coverage and effectiveness.

Vaccine Coverage

Influenza vaccine coverage estimates for the 2022-2023 season are anticipated to be available in February or March 2023.

Vaccine Effectiveness

Influenza vaccine effectiveness estimates for the 2022-2023 season are anticipated to be available in February or March 2023.

Provincial and International Surveillance Links

See Influenza surveillance resources

Notes

The data in the FluWatch report represent surveillance data available at the time of writing. All data are preliminary and may change as updates are received.

To learn more about the FluWatch program, see the Overview of influenza monitoring in Canada page.

For more information on the flu, see our Flu (influenza) web page.

We would like to thank all the FluWatch surveillance partners participating in this year's influenza surveillance program.

This report is available on the Government of Canada Influenza webpage.

Ce rapport est disponible dans les deux langues officielles.

Footnote 1

All Provinces and Territories (PTs) participate in the FluWatch outbreak surveillance system. This outbreak system monitors influenza and ILI outbreaks in long-term care facilities (LTCF), acute care facilities, schools and daycares, remote and/or isolated communities, and facilities categorized as 'other'. Not all reporting PTs report outbreaks in all these settings. All PTs report laboratory confirmed outbreaks in LTCF. Four PTs (NB, NL, NS and YK) report ILI outbreaks in schools and/or daycares and other facilities.

Return to footnote 1 referrer

Footnote 2

Influenza-associated hospitalizations are reported by Alberta, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Prince Edward Island and Yukon. Only hospitalizations that require intensive medical care are reported by Saskatchewan.

Return to footnote 2 referrer

Page details

Date modified: